These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27295112)

  • 1. Safety and effectiveness of combined antihypertensive and cholesterol-lowering therapy in high-/very high-risk patients.
    Kónyi A; Sárszegi Z; Hild G; Gaszner B
    J Comp Eff Res; 2016 Jul; 5(4):355-64. PubMed ID: 27295112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and the Tolerability of a Triple Combination of Amlodipine/Losartan/Rosuvastatin in Patients With Comorbid Essential Hypertension and Hyperlipidemia.
    Lee HY; Kim SY; Choi KJ; Yoo BS; Cha DH; Jung HO; Ryu DR; Choi JH; Lee KJ; Park TH; Oh JH; Kim SM; Choi JY; Kim KH; Shim J; Kim WS; Choi SW; Park DG; Song PS; Hong TJ; Rhee MY; Rha SW; Park SW
    Clin Ther; 2017 Dec; 39(12):2366-2379. PubMed ID: 29150250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Hypertensive and Hypercholesterolaemic Patients with the Triple Fixed Combination of Atorvastatin, Perindopril and Amlodipine: The Results of the CORAL Study.
    Simon A; Dézsi CA
    Adv Ther; 2019 Aug; 36(8):2010-2020. PubMed ID: 31183780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of Fixed Dose Combination of Ramipril/Amlodipine in Hypertensive Diabetic Patients: A Subgroup Analysis of RAMONA Trial.
    Simonyi G
    Chin Med J (Engl); 2016 May; 129(10):1224-8. PubMed ID: 27174332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial.
    Gupta A; Mackay J; Whitehouse A; Godec T; Collier T; Pocock S; Poulter N; Sever P
    Lancet; 2018 Sep; 392(10153):1127-1137. PubMed ID: 30158072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of ETC-1002, a novel investigational low-density lipoprotein-cholesterol-lowering therapy for the treatment of patients with hypercholesterolemia and type 2 diabetes mellitus.
    Gutierrez MJ; Rosenberg NL; Macdougall DE; Hanselman JC; Margulies JR; Strange P; Milad MA; McBride SJ; Newton RS
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):676-83. PubMed ID: 24385236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of changing of conventional antihypertensive therapy to a triple fixed combination therapy with rosuvastatin in high cardiovascular risk patients].
    Ageev FT; Blankova ZN; Samsonova NS
    Kardiologiia; 2018 SMar; (S3):46-54. PubMed ID: 29782289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous treatment of blood pressure and cholesterol beats the 'SILO' approach in lowering cardiovascular risk: results of the CRUCIAL study.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(2):101. PubMed ID: 21556456
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ramipril plus amlodipine and lisinopril plus amlodipine fixed dose combinations and patient's adherence].
    Simonyi G; Ferenci T
    Orv Hetil; 2016 Jan; 157(1):30-4. PubMed ID: 26708684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing cardiovascular disease in hypertension: effects of lowering blood pressure and cholesterol.
    Green R; Kwok S; Durrington PN
    QJM; 2002 Dec; 95(12):821-6. PubMed ID: 12454325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lisinopril, Amlodipine, Rosuvastatin as a Novel Fixed Combination in the Fight Against Cardiovascular Disease].
    Semenova AE; Sergienko IV
    Kardiologiia; 2017 Oct; 57(10):73-79. PubMed ID: 29276932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A fixed-dose lisinopril+amlodipine+rosuvastatin combination: prospects for its use in patients with hypertension and concomitant dyslipidemia].
    Podzolkov VI; Bragina AE; Osadchiy KK
    Ter Arkh; 2017; 89(12):133-140. PubMed ID: 29411773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, placebo-controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 patients with concomitant hypertension and dyslipidemia: the respond trial.
    Preston RA; Harvey P; Herfert O; Dykstra G; Jukema JW; Sun F; Gillen D
    J Clin Pharmacol; 2007 Dec; 47(12):1555-69. PubMed ID: 18048574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
    Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L
    Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of combination therapy with amlodipine and atorvastatin on plasma adiponectin levels in hypertensive patients with coronary artery disease: combination therapy and adiponectin.
    Li M; Xu A; Lam KS; Cheung BM; Tse HF
    Postgrad Med; 2011 Nov; 123(6):66-71. PubMed ID: 22104455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slovak trial on cardiovascular risk reduction following national guidelines with CaDUET® (the STRONG DUET study).
    Fedacko J; Pella D; Jarcuska P; Sabol F; Kmec J; Lopuchovsky T; Merkovska L; Jedlickova L; Janicko M; Sajty M
    Adv Ther; 2013 Jan; 30(1):60-70. PubMed ID: 23328937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of amlodipine and lisinopril on left ventricular mass and diastolic function in previously untreated patients with mild to moderate diastolic hypertension.
    Beltman FW; Heesen WF; Smit AJ; May JF; de Graeff PA; Havinga TK; Schuurman FH; van der Veur E; Lie KI; Meyboom-de Jong B
    Blood Press; 1998 May; 7(2):109-17. PubMed ID: 9657538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANICHKOV study: the effect of combined hypotensive and lipid-lowering therapy on cardiovascular complications in patients of high and very high risk.
    Sergienko IV; Ansheles AA; Drapkina ОМ; Gornyakova NB; Zubareva MY; Shepel RN; Kuharchuk VV; Boytsov SA
    Ter Arkh; 2019 May; 91(4):90-98. PubMed ID: 31094482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.